We next evaluated the cellular response in HD patients with previous SARS-CoV-2 infection (Figure 1B) and our results indicate that these patients achieved their peak of IFN-ɣ and IL-2 associated T cell responses ten days after the first vaccine dose (d10). This evidence concerns the gene IFNA1 and Huntington disease.